Scarica l'app Stockscreener
0.598
4.55%
0.026
Dopo l'orario di chiusura:
.61
0.012
+2.01%
Precedente Chiudi:
$0.572
Aprire:
$0.5806
Volume 24 ore:
4.47M
Relative Volume:
0.87
Capitalizzazione di mercato:
$180.42M
Reddito:
$52.29M
Utile/perdita netta:
$-134.84M
Rapporto P/E:
-0.7973
EPS:
-0.75
Flusso di cassa netto:
$-117.11M
1 W Prestazione:
-5.57%
1M Prestazione:
-11.20%
6M Prestazione:
-22.55%
1 anno Prestazione:
-64.82%
Intervallo 1D:
$0.5745
$0.6219
Intervallo di 1 settimana:
$0.562
$0.6689
Portata 52W:
$0.4111
$3.179
Sangamo Therapeutics Inc Stock (SGMO) Company Profile
Nome
Sangamo Therapeutics Inc
Settore
Industria
Telefono
(510) 970-6000
Indirizzo
501 CANAL BLVD., RICHMOND, CA
Confronta SGMO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SGMO
Sangamo Therapeutics Inc
|
0.598 | 172.58M | 52.29M | -134.84M | -117.11M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Sangamo Therapeutics Inc Stock (SGMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-13 | Aggiornamento | Truist | Hold → Buy |
| 2024-12-10 | Reiterato | H.C. Wainwright | Buy |
| 2023-11-03 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-04-28 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-02-27 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2023-01-06 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-06-13 | Ripresa | Wedbush | Neutral |
| 2021-05-04 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-01-07 | Ripresa | Guggenheim | Neutral |
| 2021-01-06 | Iniziato | Stifel | Hold |
| 2020-12-16 | Ripresa | H.C. Wainwright | Buy |
| 2020-09-08 | Iniziato | BofA Securities | Buy |
| 2020-07-07 | Iniziato | SunTrust | Buy |
| 2019-08-26 | Iniziato | H.C. Wainwright | Buy |
| 2018-11-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2018-11-09 | Downgrade | Guggenheim | Buy → Neutral |
| 2018-10-10 | Iniziato | Guggenheim | Buy |
| 2018-06-20 | Iniziato | BofA/Merrill | Buy |
| 2017-11-15 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2017-06-22 | Ripresa | Jefferies | Buy |
| 2016-11-01 | Downgrade | Wedbush | Outperform → Neutral |
| 2016-10-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2015-12-04 | Iniziato | Wells Fargo | Outperform |
| 2015-10-23 | Ripresa | Jefferies | Buy |
| 2013-05-03 | Iniziato | BioLogic Equity Research | Sell |
| 2011-02-23 | Reiterato | JMP Securities | Mkt Outperform |
| 2010-07-29 | Reiterato | Wedbush | Outperform |
| 2009-10-19 | Iniziato | Brean Murray | Sell |
| 2009-10-07 | Reiterato | Leerink Swann | Outperform |
| 2009-08-25 | Reiterato | JMP Securities | Mkt Outperform |
Mostra tutto
Sangamo Therapeutics Inc Borsa (SGMO) Ultime notizie
Is Sangamo Therapeutics Inc. stock a safe haven assetEntry Point & High Conviction Buy Zone Picks - newser.com
Will Sangamo Therapeutics Inc. stock outperform Nasdaq indexWeekly Trend Report & Low Drawdown Momentum Ideas - newser.com
Using AI based signals to follow Sangamo Therapeutics Inc.Market Trend Review & Safe Capital Preservation Plans - newser.com
Detecting price anomalies in Sangamo Therapeutics Inc. with AIJuly 2025 Decliners & Free Daily Entry Point Trade Alerts - newser.com
Sangamo Therapeutics Inc. stock chart pattern explainedMarket Activity Summary & Daily Entry Point Trade Alerts - newser.com
How Sangamo Therapeutics Inc. stock reacts to bond yieldsWeekly Trend Summary & Safe Entry Trade Signal Reports - newser.com
How Sangamo Therapeutics Inc. (GBY) stock reacts to monetary easingJuly 2025 Outlook & Stepwise Entry/Exit Trade Alerts - newser.com
Real time pattern detection on Sangamo Therapeutics Inc. stockEarnings Risk Summary & Precise Entry and Exit Recommendations - newser.com
Is Sangamo Therapeutics Inc. stock in correction or buying zoneMarket Growth Report & Smart Allocation Stock Tips - newser.com
Published on: 2025-10-31 05:14:43 - newser.com
How hedge fund analytics apply to Sangamo Therapeutics Inc. stock2025 Earnings Surprises & Stepwise Trade Signal Guides - newser.com
Why retail investors favor Sangamo Therapeutics Inc. stockJuly 2025 Chart Watch & Reliable Momentum Entry Alerts - newser.com
What machine learning models say about Sangamo Therapeutics Inc.Quarterly Growth Report & Expert Curated Trade Setups - newser.com
What analyst consensus says on Sangamo Therapeutics Inc. stockTrade Risk Report & Fast Exit/Entry Strategy Plans - newser.com
What analysts say about Sangamo Therapeutics Inc stockEarnings Per Share Trends & Big Returns, Small Investment – Learn How - earlytimes.in
Sangamo Therapeutics Announces Third Quarter 2025 Earnings Call - The Manila Times
We're Hopeful That Sangamo Therapeutics (NASDAQ:SGMO) Will Use Its Cash Wisely - Yahoo Finance
Published on: 2025-10-29 21:25:18 - newser.com
Sangamo Biosciences Granted Nasdaq Compliance Extension - TipRanks
Published on: 2025-10-27 19:21:18 - newser.com
Will Sangamo Therapeutics Inc. stock gain from strong economyRate Cut & Free Real-Time Market Sentiment Alerts - Fundação Cultural do Pará
Market Recap: How Sangamo Therapeutics Inc. (GBY) stock reacts to monetary easingWeekly Trade Summary & Real-Time Stock Price Movement Reports - Fundação Cultural do Pará
Published on: 2025-10-27 08:50:01 - newser.com
Published on: 2025-10-27 07:49:20 - newser.com
Sangamo Therapeutics Inc Azioni (SGMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):